Feb 13 (Reuters) - Johnson & Johnson JNJ.N:
JOHNSON & JOHNSON STATEMENT ON PHASE 3 E.MBRACE STUDY
J&J: NO SAFETY SIGNALS RELATED TO THE VACCINE WERE IDENTIFIED.
J&J -INDEPENDENT, SCHEDULED REVIEW FINDS INVESTIGATIONAL VACCINE REGIMEN LACKS EFFICACY IN PREVENTING INVASIVE E. COLI DISEASE (IED)
J&J: THE E.MBRACE STUDY IS BEING DISCONTINUED
Further company coverage: JNJ.N
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。